Given the quality of the board it would be extremely disappointing if we get hit with a delay.
If I recall the investor presentation correctly Rohan stated that assuming we get regulator approval in early March then the phase 1 single ascending dose study should commence in April..
If that is the case case you would assume in the near term punters will have to take their positions as the risk:reward opportunity reaches its apex point.
PYC Price at posting:
7.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)